Investors

Press releases

2023/09/14

Medivir to present at the Pareto Securities Healthcare Conference

Read more
2023/09/11

Medivir´s Partner Tango Therapeutics received FDA clearance to start the TNG348 phase 1/2 clinical study

Read more
2023/09/07

Medivir presents data on additive activity of fostrox in combination with Lenvima or sorafenib in non-clinical tumor models at ILCA

Read more

Presentations

Quarterly report presentations

Events

2023/10/27

Interim Report, January - September 2023

Read more
2023/11/23

Redeye Life Science Day

Read more
2023/11/23

Erik Penser Bank Company Event

Read more

Corporate Governance

Medivir Corporate Governance documention.

Annual General Meeting

Documentation from Medivir's Annual General Meetings.